HeartSciences (HSCS) Cash from Operations (QoQ) (2021 - 2025)
HeartSciences (HSCS) Cash from Operations (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -19.50% |
| Jul 31, 2025 | -22.80% |
| Apr 30, 2025 | 1.82% |
| Jan 31, 2025 | 25.81% |
| Oct 31, 2024 | -8.17% |
| Jul 31, 2024 | -28.03% |
| Apr 30, 2024 | 24.95% |
| Jan 31, 2024 | -112.61% |
| Oct 31, 2023 | 29.63% |
| Jul 31, 2023 | 24.57% |
| Apr 30, 2023 | -82.52% |
| Jan 31, 2023 | 5.57% |
| Oct 31, 2022 | 40.38% |
| Jul 31, 2022 | -51.95% |
| Apr 30, 2022 | -23.39% |
| Jan 31, 2022 | -25.81% |
| Oct 31, 2021 | -7.05% |